Pfizer Inc.PFE

Where PFE's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$27.72+0.07 (+0.25%)Previous close
NYSEHealthcare

PFE Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
PFE Net Debt / EBITDA historyPFE Net Debt / EBITDA from Oct 2023 to Jun 2026: low 2.64, high 12.33, latest 4.93.1.874.687.4810.2913.1Oct 23Mar 24Sep 24Jun 25Dec 25Jun 26med 3.95

PFE Net Debt / EBITDA by year

Yearly range of PFE’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 0.8 to 12.3, averaging 2.9.

PFE Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20263.74.34.94.9
20252.63.13.93.9
20243.07.312.33.0
20230.83.37.17.1
20220.80.91.00.8
20211.11.62.31.1
20202.13.25.32.8
20191.92.12.32.0
20181.82.02.12.1
20172.12.32.52.1
20162.52.62.62.5

Get notified when PFE Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.